LBO — SENTARA ALBEMARLE REGL MED CTR LLC
IRR: 35.0% | MOIC: 4.48x
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
35.0%
IRR
4.48x
MOIC
$28.9M
Entry EV
$80.7M
Exit EV
$14.9M
Equity Invested
Sources & Uses
S&UTotal · $28.9M| Item | Amount | % | Distribution |
|---|---|---|---|
| Senior Debt | $11.2M | 38.8% | |
| Sub Debt | $2.8M | 9.7% | |
| Equity | $14.9M | 51.5% | |
| Enterprise Value | $28.1M | 97.1% | |
| Transaction Fees | $0.8M | 2.9% | |
| Total Uses | $28.9M | 100.0% |
Interpretation
INTAt 4.48x MOIC and 35.0% IRR over 5 years, this deal exceeds the typical 20% hurdle — strong candidate.
Key drivers: Check the EBITDA bridge to identify highest-probability levers, the debt schedule for leverage trajectory, or the challenge solver to see what breaks the deal.
Returns Waterfall
WFL| Component | Value |
|---|---|
| Exit Ebitda | $7.7M |
| Exit Ev | $80.7M |
| Net Debt At Exit | $14.0M |
| Equity At Exit | $66.6M |
| Equity Invested | $14.9M |
| Total Value Created | $51.8M |
| Value From Growth | $51.2M |
| Value From Multiple | $1.4M |
| Value From Deleveraging | 0.0% |